El Paso TX 乳腺癌临床试验
6项针对 乳腺癌的研究正在 El Paso及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
招募中3 期
- El Paso Texas Oncology, El Paso
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
招募中3 期
- Research Site, El Paso
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
招募中3 期
- Clinical Trial Site, El Paso
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- Texas Oncology - West Texas, El Paso
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
招募中3 期
- Renovatio Clinical - El Paso, El Paso
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
招募中2/3 期
- Texas Oncology - West Texas, El Paso
其他城市的 乳腺癌试验
- New York City, NY134 项研究
- Houston, TX126 项研究
- Boston, MA111 项研究
- Nashville, TN80 项研究
- Los Angeles, CA72 项研究
- Edison, NJ68 项研究
- St. Louis, MO64 项研究
- Durham, NC63 项研究
- Queens, NY63 项研究
- Chicago, IL58 项研究
- Philadelphia, PA56 项研究
- Dallas, TX55 项研究
El Paso的其他研究
- 肥胖症10 项研究
- 超重8 项研究
- 心力衰竭7 项研究
- 非小细胞肺癌6 项研究
- 慢性阻塞性肺病5 项研究
- 转移性癌症5 项研究
- 伯基特淋巴瘤4 项研究
- 肺癌4 项研究
- 哮喘4 项研究
- 癌症（所有类型）4 项研究
- 特发性肺纤维化4 项研究
- 狼疮4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。